Keywords: sweden, approves, zeneca, zomig, pharmaceuticals, received, approval

Sweden Approves Zeneca's Zomig

Article | 25 March 1997

Zeneca Pharmaceuticals has received approval from Sweden's MedicalProducts Agency to market Zomig (zolmitriptan) for the oral treatment of acute migraine.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Zolmitriptan

Zomig

Nystatin

Go to drug listing